Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2019: 96.39
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(10): 767-777
DOI: http://dx.doi.org/10.20546/ijcmas.2016.510.083


Assessing the Appropriate Use of Proton Pump Inhibitors amongst the Outpatient Lebanese Population
George T. Nawas1, Tarek Nawas2*, Diana Malaeb3, Sarah El Helou4 and Souheil Hallit4,5
1Lebanese American University, School of Pharmacy, Byblos, Lebanon
2Lebanese American University, School of Arts and Sciences, Beirut, Lebanon
3Lebanese International University, School of Pharmacy, Beirut, Lebanon
4Lebanese University, School of Pharmacy, Hadath, Lebanon
5Universite Saint-Esprit de Kaslik, School of medicine, Kaslik, Lebanon
*Corresponding author
Abstract:

Proton pump inhibitors (PPI) are commonly prescribed for the treatment of many conditions but are currently being misused. The objective of this study was to evaluate the appropriate indication, dosage and duration of use of PPIs by outpatients in Lebanon. This cross-sectional study evaluated the treatment of 323 outpatients who presented to community pharmacies, in different Lebanese regions, with any PPI prescription. The results showed that there was a significant association between the prescribing of the PPI for the correct indication and recommending it in the appropriate dosage, but not with the type of PPI used nor with the duration of treatment that was indicated. No significant difference was found between the prescribed and over-the-counter PPIs regarding the appropriate duration of treatment, dosage and indication. A significant association was found, however, between the reason for PPI use and the other chronic diseases that the patients had and the number of cups of coffee drunk by a patient per day. PPI use by Lebanese outpatients showed to be mostly consistent with the FDA recommendations with regards to the dosage taken. However, the duration of therapy was clearly not in accordance with what is currently recommended. Physicians need to follow-up with patients and reassess the need for therapy on a regular basis.


Keywords: Proton Pump Inhibitors, Heartburn, Ulcer, GERD, Lebanon, Community pharmacy.
Download this article as Download

How to cite this article:

George T. Nawas, Tarek Nawas, Diana Malaeb, Sarah El Helou and Souheil Hallit. 2016. Assessing the Appropriate Use of Proton Pump Inhibitors amongst the Outpatient Lebanese Population.Int.J.Curr.Microbiol.App.Sci. 5(10): 767-777. doi: http://dx.doi.org/10.20546/ijcmas.2016.510.083